Literature DB >> 16352797

Ventilatory management of acute lung injury and acute respiratory distress syndrome.

Eddy Fan1, Dale M Needham, Thomas E Stewart.   

Abstract

CONTEXT: The acute lung injury and acute respiratory distress syndrome are critical illnesses associated with significant morbidity and mortality. Mechanical ventilation is the cornerstone of supportive therapy. However, despite several important advances, the optimal strategy for ventilation and adjunctive therapies for patients with acute lung injury and acute respiratory distress syndrome is still evolving. EVIDENCE ACQUISITION: To identify reports of invasive ventilatory and adjunctive therapies in adult patients with acute lung injury and acute respiratory distress syndrome, we performed a systematic English-language literature search of MEDLINE (1966-2005) using the Medical Subject Heading respiratory distress syndrome, adult, and related text words, with emphasis on randomized controlled trials and meta-analyses. EMBASE and the Cochrane Central Register of Controlled Trials were similarly searched. The search yielded 1357 potential articles of which 53 were relevant to the study objectives and considered in this review. EVIDENCE SYNTHESIS: There is strong evidence to support the use of volume- and pressure-limited lung-protective ventilation in adult patients with acute lung injury and acute respiratory distress syndrome. The benefit of increased levels of positive end-expiratory pressure and recruitment maneuvers is uncertain and is being further evaluated in ongoing trials. Existing randomized controlled trials of alternative ventilation modes, such as high-frequency oscillation and adjunctive therapies, including inhaled nitric oxide and prone positioning demonstrate no significant survival advantage. However, they may have a role as rescue therapy for patients with acute respiratory distress syndrome with refractory life-threatening hypoxemia.
CONCLUSIONS: Volume- and pressure-limited ventilation strategies should be used in managing adult acute lung injury and acute respiratory distress syndrome patients. Further research is needed to identify barriers to widespread adoption of this strategy, as well as the role of alternative ventilation modes and adjunctive therapies.

Entities:  

Mesh:

Year:  2005        PMID: 16352797     DOI: 10.1001/jama.294.22.2889

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  44 in total

Review 1.  Did studies on HFOV fail to improve ARDS survival because they did not decrease VILI? On the potential validity of a physiological concept enounced several decades ago.

Authors:  Didier Dreyfuss; Jean-Damien Ricard; Stéphane Gaudry
Journal:  Intensive Care Med       Date:  2015-10-05       Impact factor: 17.440

2.  Manipulation of inflammation in ARDS: achievable goal or distant target?

Authors:  S V Baudouin
Journal:  Thorax       Date:  2006-06       Impact factor: 9.139

3.  Frequency of adoption of practice management guidelines at trauma centers.

Authors:  Justin Sobrino; Sunni A Barnes; Nadine Dahr; Rustam Kudyakov; Candice Berryman; Avery B Nathens; Mark R Hemmila; Melanie Neal; Shahid Shafi
Journal:  Proc (Bayl Univ Med Cent)       Date:  2013-07

4.  Infections caused by multidrug resistant organisms are not associated with overall, all-cause mortality in the surgical intensive care unit: the 20,000 foot view.

Authors:  Laura H Rosenberger; Damien J LaPar; Robert G Sawyer
Journal:  J Am Coll Surg       Date:  2012-03-13       Impact factor: 6.113

5.  Improvements in pulmonary and general critical care reduces mortality following ventilator-associated pneumonia.

Authors:  Laura H Rosenberger; Tjasa Hranjec; Matthew D McLeod; Amani D Politano; Christopher A Guidry; Stephen Davies; Robert G Sawyer
Journal:  J Trauma Acute Care Surg       Date:  2013-02       Impact factor: 3.313

6.  Inhaled nitric oxide increases endothelial permeability in Pseudomonas aeruginosa pneumonia.

Authors:  Florence Ader; Rozenn Le Berre; Steve Lancel; Karine Faure; Nathalie B Viget; Emmanuel Nowak; Rémi Nevière; Benoit P Guery
Journal:  Intensive Care Med       Date:  2007-01-12       Impact factor: 17.440

7.  IL-33 Signaling in Lung Injury.

Authors:  Jing Chang; Yue-Feng Xia; Ma-Zhong Zhang; Li-Ming Zhang
Journal:  Transl Perioper Pain Med       Date:  2016

8.  What the concept of VILI has taught us about ARDS management.

Authors:  Didier Dreyfuss; Rolf Hubmayr
Journal:  Intensive Care Med       Date:  2016-03-03       Impact factor: 17.440

Review 9.  The impact of obesity on outcomes after critical illness: a meta-analysis.

Authors:  Charles W Hogue; Joshua D Stearns; Elizabeth Colantuoni; Karen A Robinson; Tracey Stierer; Nanhi Mitter; Peter J Pronovost; Dale M Needham
Journal:  Intensive Care Med       Date:  2009-02-03       Impact factor: 17.440

10.  Mitogen activated protein kinase activated protein kinase 2 regulates actin polymerization and vascular leak in ventilator associated lung injury.

Authors:  Mahendra Damarla; Emile Hasan; Adel Boueiz; Anne Le; Hyun Hae Pae; Calypso Montouchet; Todd Kolb; Tiffany Simms; Allen Myers; Usamah S Kayyali; Matthias Gaestel; Xinqi Peng; Sekhar P Reddy; Rachel Damico; Paul M Hassoun
Journal:  PLoS One       Date:  2009-02-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.